Efficacy and safety of the Ad-GM•CAIX dendritic cell-based vaccine in treating in vivo metastatic renal cell carcinoma compared to sunitinib monotherapy and simultaneous vaccine-sunitinib combination therapy

被引：0
|
作者：
Rampersaud, Edward N. [1 ]
Said, Jonathan W. [2 ]
Bot, Adrian [3 ]
Birkhaueser, Frederic D. [1 ]
Kroeger, Nils [1 ]
Zeng, Gang [1 ]
Kabbinavar, Fairooz F. [1 ]
Ribas, Antoni [4 ]
Pantuck, Allan J. [1 ]
Belldegrun, Arie S. [1 ]
Riss, Joseph [1 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Inst Urol Oncol, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA
[3] Kite Pharma Inc, Los Angeles, CA USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Div Surg Oncol, Los Angeles, CA 90095 USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-2819
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2819
引用
收藏
页数：2
相关论文
共 37 条
  • [1] EFFECTS OF DENDRITIC CELL-BASED AD-GM CAIX VACCINE AS MONOTHERAPY OR IN COMBINATION WITH SUNITINIB IN AN IMMUNOCOMPETENT MOUSE MODEL OF METASTATIC RENAL CELL CARCINOMA
    Rampersaud, Edward N.
    Said, Jonathan W.
    Bot, Adrian
    Birkhaeuser, Frederic D.
    Kroeger, Nils
    Zeng, Gang
    Kabbinavar, Fairooz F.
    Ribas, Antoni
    Pantuck, Allan J.
    Belldegrun, Arie S.
    Riss, Joseph
    JOURNAL OF UROLOGY, 2014, 191 (04): : E372 - E372
  • [2] Dendritic Cell-Based Immunotherapy Combined with Sunitinib for Metastatic Renal Cell Carcinoma
    Enomoto, Y.
    Kume, H.
    Fukuhara, H.
    Fujimura, T.
    Suzuki, M.
    Nishimatsu, H.
    Ishikawa, A.
    Matsushita, H.
    Kakimi, K.
    Homma, Y.
    UROLOGY, 2012, 80 (03) : S254 - S254
  • [3] Dendritic cell-based vaccine therapy in patients with renal cell carcinoma
    Nosov, D. A.
    Borunova, A. A.
    Chkadua, G. Z.
    Matveyev, V. B.
    Yakovleva, E. S.
    Fedyanin, M. Yu.
    Kadagidze, Z. G.
    Zabotina, T. N.
    Tyulyandin, S. A.
    ONKOUROLOGIYA, 2010, 6 (02): : 22 - 31
  • [4] Dendritic Cell-Based Immunotherapy in Prevention and Treatment of Renal Cell Carcinoma: Efficacy, Safety, and Activity of Ad-GM.CAIX in Immunocompetent Mouse Models
    Birkhaeuser, Frederic D.
    Koya, Richard C.
    Neufeld, Caleb
    Rampersaud, Edward N.
    Lu, Xuyang
    Micewicz, Ewa D.
    Chodon, Thinle
    Atefi, Mohammad
    Kroeger, Nils
    Chandramouli, Gadisetti V. R.
    Li, Gang
    Said, Jonathan W.
    McBride, William H.
    Kabbinavar, Fairooz F.
    Ribas, Antoni
    Pantuck, Allan J.
    Belldegrun, Arie S.
    Riss, Joseph
    JOURNAL OF IMMUNOTHERAPY, 2013, 36 (02) : 102 - 111
  • [5] In vivo safety and efficacy of a novel dendritic cell based Ad-GMCAIX vaccine with activity against renal cell carcinoma
    Birkhauser, Frederic D.
    Koya, Richard C.
    Neufeld, Caleb
    Lu, Xuyang
    Micewicz, Ewa D.
    Chodon, Thinie
    Atefi, Mohammad
    Kroeger, Nils
    Rampersaud, Edward N.
    Chandramouli, Gadisetti V. R.
    Li, Gang
    Said, Jonathan W.
    Ribas, Antoni
    McBride, William H.
    Kabbinavar, Fairooz F.
    Pantuck, Allan J.
    Belldegrun, Arie S.
    Riss, Joseph
    CANCER RESEARCH, 2012, 72
  • [6] Safety and efficacy of the combination of erlotinib and sirolimus for the treatment of metastatic renal cell carcinoma after failure of sunitinib or sorafenib
    Flaig, T. W.
    Costa, L. J.
    Gustafson, D. L.
    Breaker, K.
    Schultz, M. K.
    Crighton, F.
    Kim, F. J.
    Drabkin, H.
    BRITISH JOURNAL OF CANCER, 2010, 103 (06) : 796 - 801
  • [7] Safety and efficacy of the combination of erlotinib and sirolimus for the treatment of metastatic renal cell carcinoma after failure of sunitinib or sorafenib
    T W Flaig
    L J Costa
    D L Gustafson
    K Breaker
    M K Schultz
    F Crighton
    F J Kim
    H Drabkin
    British Journal of Cancer, 2010, 103 : 796 - 801
  • [8] Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study
    Amin, Asim
    Plimack, Elizabeth R.
    Ernstoff, Marc S.
    Lewis, Lionel D.
    Bauer, Todd M.
    McDermott, David F.
    Carducci, Michael
    Kollmannsberger, Christian
    Rini, Brian I.
    Heng, Daniel Y. C.
    Knox, Jennifer
    Voss, Martin H.
    Spratlin, Jennifer
    Berghorn, Elmer
    Yang, Lingfeng
    Hammers, Hans J.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [9] Combination therapy with dendritic cell-based vaccine and anti-CD69 antibody enhances antitumor efficacy in renal cell carcinoma-bearing mice
    Wei, Si-Ming
    Pan, Hang-Li
    Wang, Li
    Yin, Guo-Li
    Zhong, Kai
    Zhou, Ya
    Yang, Shu-Jiao
    Xin, Zhao-Liang
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2017, 47 (02) : 658 - 667
  • [10] Phase II study combining personalized dendritic cell (DC)-based therapy, AGS-003, with sunitinib in metastatic renal cell carcinoma (mRCC).
    Figlin, Robert A.
    Amin, Asim
    Dudek, Arkadiusz
    Logan, Theodore
    Lance, Raymond S.
    Holzbeierlein, Jeffrey M.
    Master, Viraj A.
    Pal, Sumanta Kumar
    Gamble, Alicia H.
    DeBenedette, Mark
    Tcherepanova, Irina Y.
    Williams, W. Lee
    Plessinger, Doug
    Miesowicz, Fred
    Nicolette, Charles A.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
1234